Mylan to infuse USD 1 billion on capex in India Medical Dialogues Bureau30 Sept 2019 9:30 AM ISTMylan Global President and Executive Director Rajiv Malik said the company had been investing close to about USD 400 million or USD 450 million...
Health Ministry reprimands CDSCO officers for frequent visit to ministry office Farhat Nasim29 Sept 2019 12:30 PM ISTAll CDSCO officers have been accordingly advised by the Health Ministry via the circular to be careful and not to visit the Ministry except on being...
Biocon chief Kiran Shaw vows to cut cost of rh-Insulin Medical Dialogues Bureau29 Sept 2019 10:00 AM ISTNew Delhi: Biocon Chief, Kiran Mazumdar-Shaw, Philanthropist and Founder of Biocon, recently, announced her personal commitment towards enabling...
Abbott neurostimulation system Proclaim XR gets USFDA nod for chronic pain Medical Dialogues Bureau29 Sept 2019 9:55 AM ISTProclaim XR is currently under review for CE Mark. It is the latest advancement from Abbott, featuring upgradeable software and consumer-friendly...
Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder Medical Dialogues Bureau28 Sept 2019 2:38 PM IST"Solifenacin Succinate Tablet is a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US, Inc, " Strides Pharma said.Bangalore:...
A Vaidheesh re-elected President of OPPI for the third consecutive year Medical Dialogues Bureau28 Sept 2019 10:26 AM ISTA. Vaidheesh, Vice President, South Asia & Managing Director, GlaxoSmithKline Pharmaceuticals Ltd. has been re-elected as the President for OPPI,...
Eisai Pharma, Mylan sign agreement commercialize metastatic breast cancer drug TECERIS in India Medical Dialogues Bureau28 Sept 2019 9:57 AM ISTNew Delhi- Eisai Pharmaceuticals India Pvt. Ltd and Mylan Pharmaceuticals Pvt Ltd. (Mylan), jointly announced that they have entered into a marketing...
Zydus receives final approval from USFDA for Clobetasol Propionate Lotion Medical Dialogues Bureau28 Sept 2019 9:02 AM ISTNew Delhi: Zydus Cadila has received the final approval from the USFDA to market Clobetasol Propionate Lotion, (US RLD - Clobex Lotion),...
Cipla launches skin treatment Daptomycin Injection in US Medical Dialogues Bureau27 Sept 2019 1:53 PM ISTDrug firm Cipla on Wednesday said it has launched Daptomycin Injection, used for treating complicated skin infections, in the US market. Daptomycin...
Fraud: SEBI bars Morepen from market for 1 year Medical Dialogues Bureau27 Sept 2019 1:44 PM ISTNew Delhi: Capital markets regulator SEBI on Tuesday barred Morepen Laboratories from the capital markets for one year for making misleading...
CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers Meghna A Singhania27 Sept 2019 12:19 PM ISTNew Delhi : Taking into consideration, the proposal on measures need to be taken to address the issue of repacking of Active Pharmaceutical...
AstraZeneca India bags DCGI marketing nod for QTERN-once-daily anti-diabetes drug Medical Dialogues Bureau27 Sept 2019 11:54 AM IST26 September 2019: AstraZeneca Pharma India Limited (AstraZeneca India) announced that it has received Import & Market permission for QTERN®...
